Journal of Natural Products 2013-04-26

Α-mangostin and gambogic acid as potential inhibitors of the p53-MDM2 interaction revealed by a yeast approach.

Mariana Leão, Sara Gomes, José Pedraza-Chaverri, Neuza Machado, Emília Sousa, Madalena Pinto, Alberto Inga, Clara Pereira, Lucília Saraiva

Index: J. Nat. Prod. 76(4) , 774-8, (2013)

Full Text: HTML

Abstract

α-Mangostin (1) and gambogic acid (2) are natural products with potent cytotoxic activity against several human tumor cells. However, their molecular mechanisms of action remain controversial. In this work, using yeast-based assays, it was shown that both xanthones are potential inhibitors of the p53-MDM2 interaction. This activity on p53-MDM2 interaction was confirmed by a gene reporter assay in a human tumor cell. Additionally, computational docking studies supported the potential of these xanthones to bind to MDM2 and therefore act as putative MDM2 inhibitors. Altogether, this work provides a new insight concerning the molecular basis of activity for these compounds.

Related Compounds

  • Gambogic Acid
  • alpha-Mangostin

Related Articles:

Induction of programmed erythrocyte death by gambogic acid.

2012-01-01

[Cell Physiol. Biochem. 30(2) , 428-38, (2012)]

Gambogic acid as a non-competitive inhibitor of ATP-binding cassette transporter B1 reverses the multidrug resistance of human epithelial cancers by promoting ATP-binding cassette transporter B1 protein degradation.

2013-01-01

[Basic Clin Pharmacol Toxicol. 112(1) , 25-33, (2013)]

Subcellular localization and activity of gambogic acid.

2012-05-29

[ChemBioChem. 13(8) , 1191-8, (2012)]

Studies on chemical structure modification and structure-activity relationship of derivatives of gambogic acid at C(39).

2012-08-01

[Chem. Biodivers. 9(8) , 1579-90, (2012)]

Interaction between Gambogic acid and dihydrofolate reductase and synergistic lethal effects with methotrexate on hepatoma cells.

2013-01-01

[Anticancer Res. 33(1) , 133-42, (2013)]

More Articles...